-+ 0.00%
-+ 0.00%
-+ 0.00%

PROTAGONIST THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $150.00 FROM $110.00

路透·08/06/2026 02:50:05

登录查看新闻详情